Dymon Asia Capital (Singapore) Pte. Ltd. Amgen Inc Transaction History
Dymon Asia Capital (Singapore) Pte. Ltd.
- $429 Million
- Q1 2025
A detailed history of Dymon Asia Capital (Singapore) Pte. Ltd. transactions in Amgen Inc stock. As of the latest transaction made, Dymon Asia Capital (Singapore) Pte. Ltd. holds 40,000 shares of AMGN stock, worth $11.2 Million. This represents 2.91% of its overall portfolio holdings.
Number of Shares
40,000Holding current value
$11.2 Million% of portfolio
2.91%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding AMGN
# of Institutions
3,312Shares Held
429MCall Options Held
8.06MPut Options Held
7.7M-
Vanguard Group Inc Valley Forge, PA52.9MShares$14.8 Billion0.31% of portfolio
-
Black Rock Inc. New York, NY46MShares$12.9 Billion0.33% of portfolio
-
State Street Corp Boston, MA29.2MShares$8.14 Billion0.38% of portfolio
-
Capital World Investors Los Angeles, CA16.7MShares$4.66 Billion0.88% of portfolio
-
Morgan Stanley New York, NY16.2MShares$4.53 Billion0.37% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $149B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...